We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Transdermal Drug Delivery Company, Medherant, Have Raised £3.8 M in Funding

Product News   Dec 11, 2017 | Medherant

 
Transdermal Drug Delivery Company, Medherant, Have Raised £3.8 M in Funding
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

The Native Antigen Company Launches SARS-CoV-2 Specific Antibodies

Product News

The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), today announced the introduction of ten new monoclonal antibodies recognising SARS-CoV-2, the causative agent of COVID-19.

READ MORE

Enterprise Therapeutics’ First Potentiator Program for Treatment of Respiratory Diseases Acquired by Roche

Product News

Enterprise Therapeutics Ltd (Enterprise), today announced its novel TMEM16A potentiator portfolio has been fully acquired by Roche and will be developed by Genentech. The portfolio includes ETD002 which recently entered Phase 1 trials.

READ MORE

New Collaboration Explores Efficacy of Gene Delivery Vector Tech in Diabetes and Multiple Sclerosis

Product News

Amarna Therapeutics has announced today that it has entered into a collaboration with scientists from the Progreso y Salud Foundation (FPS) at Cabimer in Seville, to jointly examine the efficacy of Amarna’s SVec™ gene delivery vector for the development of effective immunotherapies for diabetes mellitus type 1 (DM1) and multiple sclerosis (MS).

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE